Vaxart Inc. (VXRT)
NASDAQ: VXRT
· Real-Time Price · USD
0.49
-0.04 (-7.98%)
At close: Jun 27, 2025, 3:59 PM
-7.98% (1D)
| Bid | 0.49 |
| Market Cap | 112.28M |
| Revenue (ttm) | 47.4M |
| Net Income (ttm) | -58.12M |
| EPS (ttm) | -0.26 |
| PE Ratio (ttm) | -1.89 |
| Forward PE | -1.41 |
| Analyst | Buy |
| Ask | 0.52 |
| Volume | 2,801,475 |
| Avg. Volume (20D) | 4,300,916 |
| Open | 0.54 |
| Previous Close | 0.53 |
| Day's Range | 0.48 - 0.54 |
| 52-Week Range | 0.28 - 1.07 |
| Beta | 1.15 |
About VXRT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VXRT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VXRT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+28.3%
Vaxart shares are trading higher after the company...
Unlock content with
Pro Subscription
7 months ago
+1.5%
Vaxart shares are trading higher after the company announced its Phase 2b COVID-19 trial received Independent Data Safety Monitoring Board (DSMB) approval and will expand its testing to 10,000 participants.
